FactSet (FDS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Jan, 2026Executive summary
Q2 FY2025 GAAP revenues reached $570.7 million, up 4.5% year over year, with organic revenues up 4.0% to $568.0 million, driven by wealth, corporates, and institutional buy-side clients.
Organic ASV grew 4.1% year-over-year to $2,276.2 million, with buy-side clients accounting for over 82% of organic ASV and client base expanding to over 8,600.
Adjusted operating margin was 37.3% (down 100 bps), and adjusted diluted EPS rose 1.4% to $4.28; GAAP diluted EPS increased 3.0% to $3.76.
Free cash flow for Q2 was $150.2 million, up 23.3% year over year, reflecting higher net cash from operating activities.
Major enterprise wins included UBS in wealth management, and acquisitions of Irwin, LiquidityBook, and LogoIntern are driving cross-sell opportunities and workflow automation.
Financial highlights
Q2 FY2025 revenues: $570.7 million (+4.5% YoY); organic revenues up 4.0% to $568 million.
Adjusted operating margin was 37.3% (down 100 bps); GAAP operating margin at 32.5% (down 80 bps YoY).
Adjusted EPS increased 1.4% to $4.28; GAAP diluted EPS up 3.0% to $3.76.
EBITDA grew 3.6% to $224.6 million; free cash flow up 23% to $150.2 million.
Returned $392 million to shareholders over 12 months via dividends and buybacks; $186.9 million remains authorized for repurchases.
Outlook and guidance
Fiscal 2025 organic ASV growth expected between $100 million and $130 million (4.4% to 5.8%).
Revenue guidance raised to $2.305–$2.325 billion, reflecting recent acquisitions.
Adjusted operating margin guidance maintained at 36%–37%; adjusted EPS at $16.80–$17.40.
GAAP operating margin expected at 32%–33%; GAAP EPS at $14.80–$15.40, reflecting one-time acquisition costs.
Anticipates higher second-half expenses for GenAI and infrastructure investments.
Latest events from FactSet
- Q3 saw higher revenues, margins, and EPS, with raised profit guidance and continued capital returns.FDS
Q3 20243 Feb 2026 - Revenue and EPS beat guidance, with strong 2025 outlook and continued capital returns.FDS
Q4 202420 Jan 2026 - AI-powered innovation and reaffirmed guidance drive growth and margin expansion through 2028.FDS
Investor Day 202414 Jan 2026 - Q1 revenue up 4.9%, adjusted EPS up 6.1%, guidance and client growth remain strong.FDS
Q1 202510 Jan 2026 - Q1 revenue up 6.9%, organic ASV up 5.9%, and share repurchase authorization expanded.FDS
Q1 20265 Jan 2026 - Shareholders to vote on board, auditor, compensation, new plans, and governance reforms.FDS
Proxy Filing1 Dec 2025 - Board backs all director nominees, auditor ratification, say-on-pay, and opposes lowering special meeting threshold.FDS
Proxy Filing1 Dec 2025 - Board recommends FOR all proposals, including new equity plans and governance enhancements.FDS
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay up for vote at annual meeting.FDS
Proxy Filing1 Dec 2025